Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the University of Warwick
Poolbeg Pharma PLC (POLB.L) Exclusive license of RNA-based immunotherapy asset
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 via Vox Markets
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is what
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 via Vox Markets
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is what
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 Countdown – 4 to 1 (Part 4) via Vox Markets
The Top 20 For 2022: Of course, at this time of the year, everyone and their mother deliver their list for the winners of the New Year, as I have in
Poolbeg Pharma (LSE:POLB) Year in (Video) Review 2021
Targeting the growing infectious disease market, we are developing multiple assets quickly to Phase II ready with plans to monetise early to Big Pharma. POLB spun out of Open Orphan
RNS Hotlist with Zak Mir, 21st December 2021, ORPH, IME, XTR, EUA, JAN, BEM, FRG, TUN, ROQ & GST via Vox Markets
Another day, another contract win from Open Orphan (ORPH), the specialist contract research organisation and vaccine and antiviral testing company using human challenge clinical trials. It announced that hVIVO, a
Open Orphan PLC (ORPH.L) £5m Influenza human challenge study contract win
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO
Share Talk catches up with CEO Jeremy Skillington, Poolbeg Pharma (LON: POLB) Interview
Share Talk caught up with our CEO to discuss yesterday’s announcement on #POLB’s has signed a binding term sheet, encompassing all commercial terms, with AnaBio Technologies (AnaBio), with a full
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 16th December 2021 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London market. Today’s selection includes Blue Star, Block, Eurasia, Gild, i3, Kodal, Open Orphan,
Poolbeg Pharma (POLB.L) agrees terms to develop an oral vaccine delivery platform
16 December, 2021- Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed a binding term sheet,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 10th December 2021 via Vox Markets
Zak Mir takes a charting perspective to some of the most followed small caps on the London market. Today’s selection includes Bens, DeepVerge, Greatland, Nanosynth, Open Orphan, President, Pathfinder, Rockhopper,
